Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
Published Date: 13 Mar 2023
Italy: Treatment with SGLT2 inhibitors in patients with type 2 diabetes (T2D) is associated with a reduced risk of restenosis in the stent...
Read Full NewsNew findings from the EMBARK study highlight Elevidys' significant long-term benefits in slowing Duchenne muscular dystrophy progression in young patients.
A study of 614 brain donors revealed that individuals with stage III or IV CTE face the greatest risk of dementia.
FDA Approves First Dual-Agent Eye Drop for Near Vision Loss
1.
Screening for prostate cancer: is it time to give up digital rectal examination?
2.
Research identifies nearly 200 potential breast carcinogens in food packaging materials
3.
Cancer diagnosis does not spur improvements to survivors' diets or eating habits
4.
Ultrasound bras; HPV and thyroid cancer; language minimizing adverse events.
5.
Oleanolic acid from grapes may increase chemotherapy effectiveness
1.
A Glimmer of Hope: The Predictive Power of Liquid Biopsy and AI in Palliative Oncology
2.
CA-125 Test: Why It's Important for Women's Health and Early Detection of Ovarian Cancer
3.
Exploring The Causes and Consequences of Low Transferrin Saturation
4.
Effective Management Strategies for Sickle Cell Crisis: Insights from Medical Experts
5.
Understanding Protein C Deficiency: Symptoms, Causes, and Treatment
1.
International Lung Cancer Congress®
2.
Future NRG Oncology Meeting
3.
Genito-Urinary Oncology Summit 2026
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
L858R Mutation- An Overview of Retrospective Cohort Study in Advanced NSCLC Patients
2.
An Eagles View - Evidence-based discussion on Iron Deficiency Anemia
3.
Newer Immunotherapies for Myeloma- A Comprehensive Overview- Part II
4.
Targeting Oncologic Drivers with Dacomitinib: A New Approach to Lung Cancer Treatment
5.
Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma - Part IV
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Join to enhance your clinical skills and gain specialized in-depth medical knowledge